Safe Care CommitmentExpert care for in-person and virtual visits; Hospital visitor policyLearn more
Development of an imaging probe to visualize Alzheimer's disease-related gamma-secretase in the brain. Development of an imaging probe to visualize Alzheimer's disease-related gamma-secretase in the brain. Key Takeaways • Researchers have developed
Virtual Visits at Mass General have grown exponentially in the wake of COVID-19 and its related stay-at-home orders.
AMX0035 is the first investigational therapy to demonstrate statistically significant benefit in people with ALS since approved therapies riluzole and edaravone.
The system can be used to monitor DNA repair pathways directly in animals as well as cell lines. No such system previously existed for in vivo studies. These pathways play a crucial role in multiple conditions, including cancer.
The Effects of Sedation on Brain Function in COVID-19 Patients. The Effects of Sedation on Brain Function in COVID-19 Patients. Although treatment for those with COVID-19 has improved, concerns about neurological complications continue to
Single-cell analysis provides new insights into mitochondrial diseases. Single-cell analysis provides new insights into mitochondrial diseases. Key Takeaways • Inherited mutations in mitochondrial DNA often cause mitochondrial diseases and affected
Aunque los investigadores están empezando a comprender los síntomas que subyacen a las secuelas neurológicas de la infección por el SARS-CoV-2, los efectos directos e indirectos del SARS-CoV-2 en el cerebro siguen sin estar claros.
With the help of donors including the Byrne Family, the Judith and Jean Pape Adams Foundation and the Cullen Education and Research Fund, these new young investigators will have the opportunity to play a central role in breaking down current barriers, accelerating the translation of research findings into care, and expanding treatment access to innovative and personalized therapeutic trials.
As the first ever platform trial for ALS, the HEALEY ALS Platform Trial is testing three proposed drug regimens and will add two more over the next several months.
Neuroscience team is first in New England to offer patients new implant blending personal technology and standardized care.
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.